AtriCure, Inc. Files 8-K on Financials
Ticker: ATRC · Form: 8-K · Filed: Feb 12, 2025 · CIK: 1323885
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: ATRC
TL;DR
ATRC filed an 8-K detailing financial results and exhibits as of Feb 12, 2025.
AI Summary
AtriCure, Inc. filed an 8-K on February 12, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing details the company's financial performance and provides relevant exhibits for the period ending February 12, 2025. The company is incorporated in Delaware and its principal executive offices are located in Mason, Ohio.
Why It Matters
This filing provides investors with crucial updates on AtriCure's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) that reports on existing conditions rather than announcing new, significant events.
Key Players & Entities
- AtriCure, Inc. (company) — Registrant
- February 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Mason, OH (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for AtriCure, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, and to file Financial Statements and Exhibits.
On what date is the earliest event reported in this filing?
The earliest event reported is dated February 12, 2025.
In which state is AtriCure, Inc. incorporated?
AtriCure, Inc. is incorporated in Delaware.
What is the address of AtriCure, Inc.'s Principal Executive Offices?
The Principal Executive Offices are located at 7555 Innovation Way, Mason, OH 45040.
What is the SEC File Number for AtriCure, Inc.?
The SEC File Number for AtriCure, Inc. is 000-51470.
Filing Stats: 582 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2025-02-12 16:00:20
Filing Documents
- atrc-20250212.htm (8-K) — 27KB
- atrc-20250212xexx991.htm (EX-99.1) — 156KB
- image_0.jpg (GRAPHIC) — 3KB
- 0001323885-25-000005.txt ( ) — 321KB
- atrc-20250212.xsd (EX-101.SCH) — 2KB
- atrc-20250212_lab.xml (EX-101.LAB) — 21KB
- atrc-20250212_pre.xml (EX-101.PRE) — 12KB
- atrc-20250212_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On February 12, 2025 , AtriCure, Inc. issued a press release regarding its financial results for the fourth quarter and full-year ended December 31, 2024. The Company will hold a conference call on February 12, 2025 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in Item 2.02 of Form 8-K and in the press release attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Form 8-K and Exhibit 99.1 shall not be incorporated by reference in any filing or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing or document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 99.1 Press Release dated February 12, 2025, relating to financial results for the fourth quarter and full year ended December 31, 2024. 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATRICURE, INC. Dated: February 12, 2025 By: /s/ Angela L. Wirick Angela L. Wirick Chief Financial Officer